Martin Lange
Corporate Officer/Principal presso NOVO NORDISK A/S
Posizioni attive di Martin Lange
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2018 | - |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Direttore/Membro del Consiglio | 18/08/2023 | - |
Storia della carriera di Martin Lange
Precedenti posizioni note di Martin Lange
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 01/01/2017 | 20/02/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Direttore/Membro del Consiglio | 01/01/2006 | 01/01/2008 |
Formazione di Martin Lange
| University of Copenhagen | Doctorate Degree |
Statistiche
Distribuzione geografica
| Danimarca | 4 |
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Aziende private | 3 |
|---|---|
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Martin Lange
- Esperienza